KYLE FETTEROLF: Open Payments
NPI 1477529501 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 52 payments from 9 companies in 2025. Trend: 2023 $401 · 2024 $433 · 2025 $1,314
Food & beverage: $1,309Education: $5
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $546 |
| Sumitomo Pharma America, Inc. | 19 | $395 |
| Astellas Pharma US Inc | 4 | $94 |
| Telix Pharmaceuticals | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $58 |
| PFIZER INC. | 2 | $52 |
| ABBVIE INC. | 2 | $40 |
| Teleflex LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $27 |
Products named: GEMTESA, Xofigo, Nubeqa, Xtandi, ILLUCCIX, ERLEADA, ELIQUIS, LUPRON DEPOT.
Industry payments across PA — which companies pay providers there.
